Status:
RECRUITING
Integrated Mindfulness-based Health Qigong Intervention for COVID-19 Survivors and Caregivers
Lead Sponsor:
The Hong Kong Polytechnic University
Conditions:
COVID-19 Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
COVID-19-related depression, anxiety, and stigma are expected to have short-term and long-term adverse impacts on mental health, help seeking and preventive behaviours in affected individuals, includi...
Detailed Description
Objective: The study aims to examine whether iMBHQ can improve the physical and psychological wellness of COVID-19 survivors, caregivers and the general public in the community. Procedures: Partici...
Eligibility Criteria
Inclusion
- COVID-19 survivors: people aged 18 years or above who were infected by COVID-19 (both symptomatic and asymptomatic) and clinically recovered
- Caregivers of COVID-19 patients, including family members or medical professionals who have contacts with patients diagnosed COVID-19 aged 18 years or above
- General healthy public aged 18 years or above
Exclusion
- people diagnosed severe and/or chronic conditions that prevent the practice of Qigong (e.g., acute exacerbation of dyspnoea, severe cardiopulmonary disease) or mindfulness intervention,
- people with severe psychiatric disorder
- people who have regular psychiatric follow-ups
Key Trial Info
Start Date :
January 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06194357
Start Date
January 30 2023
End Date
September 30 2026
Last Update
January 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Hospital
Hong Kong, Hong Kong, 852